Skip to main content
OpenTrials

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,125 public trials 393 recruiting studies
Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial

NCT00002267

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Actinomycetales Infections, +23 more
Locations
  • Maricopa County Med Ctr Phoenix, Arizona, United States
  • East Bay AIDS Ctr Berkeley, California, United States
  • Pacific Oaks Med Group Beverly Hills, California, United States
  • AIDS Community Research Consortium Redwood City, California, United States
View all 43 locations
View Trial Details
Completed

A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDS

NCT00002116

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
Locations
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
  • UCSF - San Francisco Gen Hosp San Francisco, California, United States
  • Mount Zion Med Ctr / UCSF San Francisco, California, United States
  • Rush Presbyterian - Saint Luke's Med Ctr Chicago, Illinois, United States
View Trial Details
Completed

Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)

NCT00002079

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Dr Marcus Conant San Francisco, California, United States
  • Shared Med Research Foundation Tarzana, California, United States
  • Stratogen of South Florida Miami Beach, Florida, United States
  • Saint Joseph's Hosp / Infectious Disease Rsch Institute Tampa, Florida, United States
View Trial Details
Completed

The Safety and Effectiveness of Indinavir Sulfate Plus Efavirenz

NCT00002387

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • UCSD Treatment Ctr / Dept of Medicine & Pediatrics San Diego, California, United States
  • San Francisco Gen Hosp San Francisco, California, United States
  • Univ of Colorado / Health Science Ctr Denver, Colorado, United States
  • Hawaii AIDS Clinical Trial Unit Honolulu, Hawaii, United States
View Trial Details
Completed

A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ Cell

NCT00002323

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Highland Gen Hosp / San Francisco Gen Hosp Oakland, California, United States
  • Northwestern Univ Med School Chicago, Illinois, United States
  • Johns Hopkins Hosp Baltimore, Maryland, United States
  • Washington Univ School of Medicine St Louis, Missouri, United States
View Trial Details

Related conditions